Frank Lanza
Director of Finance/CFO at HARPOON THERAPEUTICS, INC.
Network origin in Frank Lanza first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Biotechnology | 26 | |
| Subsidiary | Biotechnology | 21 | |
| Extinct | Pharmaceuticals: Major | 5 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Frank Lanza via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| LINEAGE CELL THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Director of Finance/CFO Chief Executive Officer Director/Board Member Chairman Director/Board Member Chairman Director/Board Member Chief Tech/Sci/R&D Officer Chief Executive Officer General Counsel | |
| ONCOCYTE CORPORATION | Biotechnology | Director/Board Member Director of Finance/CFO Chairman Director/Board Member Chairman Director/Board Member | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO Corporate Officer/Principal Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
| GERON CORPORATION | Biotechnology | Founder Corporate Officer/Principal Chief Operating Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| The Wharton School of the University of Pennsylvania | College/University | Undergraduate Degree Masters Business Admin Masters Business Admin Masters Business Admin | |
| MALLINCKRODT PLC | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member General Counsel General Counsel | |
| QUESTCOR PHARMACEUTICALS INC | Pharmaceuticals: Major | Chief Operating Officer Chief Executive Officer Director of Finance/CFO Corporate Officer/Principal | |
| DYNAVAX TECHNOLOGIES CORPORATION | Biotechnology | Director/Board Member Director/Board Member Chairman | |
| PFIZER, INC. | Pharmaceuticals: Major | Private Equity Investor Corporate Officer/Principal Chief Operating Officer | |
| University of California, Davis | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal Undergraduate Degree Undergraduate Degree | |
| The University of California, San Francisco | College/University | Doctorate Degree Doctorate Degree Corporate Officer/Principal | |
ES Cell International Pte Ltd.
 ES Cell International Pte Ltd. BiotechnologyHealth Technology ES Cell International Pte Ltd. develops human embroyonic stem cell technologies for research and commercial applications. It develops an array of intellectual property in the fields of drug discovery, diagnostics, and therapeutics based on stem cell technology. The company was founded by Ariff Bongso, Robert Klupacs, Martin F. Pera, Reubinoff Benjamin and Alan Osborne Trounson in 2000 and is headquartered in Singapore. | Biotechnology | Chief Executive Officer Chairman | |
| SEAGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| TURMERIC ACQUISITION CORP. | Financial Conglomerates | Chief Executive Officer Director/Board Member | |
| ITERUM THERAPEUTICS PLC | Pharmaceuticals: Major | Chairman Director/Board Member | |
| HOSPIRA, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Pennsylvania | College/University | Graduate Degree Undergraduate Degree | |
| Chapman University | College/University | Director/Board Member Graduate Degree | |
OrthoCyte Corp.
 OrthoCyte Corp. Pharmaceuticals: MajorHealth Technology Part of Lineage Cell Therapeutics, Inc., OrthoCyte Corp. develops cellular therapeutics for orthopedic repair diseases and injuries. The company is based in Alameda, CA. The CEO of the company is Michael D. West. | Pharmaceuticals: Major | Chief Executive Officer Chairman | |
| BioTime Asia Ltd. | Chief Executive Officer Chairman | ||
| Massachusetts Institute of Technology | College/University | Corporate Officer/Principal Doctorate Degree | |
Ascendance Biotechnology, Inc.
 Ascendance Biotechnology, Inc. BiotechnologyHealth Technology Ascendance Biotechnology, Inc. engages in the sale of cell-based assay products. It offers Hepregen and ESI Bio. The firm also offers stem cell technology. The company was founded by Vincent R. Zurawski, Jr. and Jeffrey D. Janus is headquartered in Alameda, CA. | Biotechnology | Director/Board Member Director/Board Member | |
ReCyte Therapeutics, Inc.
 ReCyte Therapeutics, Inc. BiotechnologyHealth Technology ReCyte Therapeutics, Inc. operates as a regenerative medicine company. It focuses on repair of vascular disorders, including both age-related diseases and injuries. The company was founded in January 2011 and is headquartered in Alameda, CA. | Biotechnology | Chief Executive Officer Director/Board Member | |
| WEREWOLF THERAPEUTICS, INC. | Pharmaceuticals: Major | Founder Founder | |
LifeMap Sciences, Inc.
 LifeMap Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Atlas Capital Partners Ltd., LifeMap Sciences, Inc. is a company that provides stem cell information services. The company is based in Alameda, CA. The CEO of the company is Yaron Guan-Golan. LifeMap Sciences was acquired by Atlas Capital Partners Ltd. from AgeX Therapeutics, Inc. on March 15, 2021 for $0.50 million. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
| EXELIXIS, INC. | Pharmaceuticals: Major | General Counsel Chief Tech/Sci/R&D Officer | |
| University of California, Berkeley | College/University | Undergraduate Degree Corporate Officer/Principal | |
| Columbia Business School | College/University | Masters Business Admin Masters Business Admin | |
| Kellogg School of Management | College/University | Masters Business Admin Masters Business Admin | |
| Rensselaer Polytechnic Institute | College/University | Undergraduate Degree Undergraduate Degree | |
Rainier Therapeutics, Inc.
 Rainier Therapeutics, Inc. BiotechnologyHealth Technology Rainier Therapeutics, Inc. operates as a biotechnology company that develops a targeted biologic for the potential treatment of metastatic bladder cancer. It provides Vofatamab, an antibody that is focused on the fibroblast growth factor of bladder and other cancer. The company was founded by Stephen Lau and is headquartered in San Leandro, CA. | Biotechnology | Director of Finance/CFO Chief Executive Officer | |
| Stanford University School of Medicine | College/University | Doctorate Degree Doctorate Degree | |
| Princeton University | College/University | Undergraduate Degree Doctorate Degree | |
| Santa Clara University | College/University | Masters Business Admin Undergraduate Degree | |
Maverick Therapeutics, Inc.
 Maverick Therapeutics, Inc. BiotechnologyHealth Technology Maverick Therapeutics, Inc. operates as a preclinical stage biotech company. It develops a novel class of T cell- redirecting antibody therapeutics that have the potential to substantially broaden the range of targets and clinical applications to be used for this ultra-potent mechanism. The company was founded by Robert Dubridge and Patrick A. Baeuerle in 2016 and is headquartered in Brisbane, CA. | Biotechnology | Founder Founder | |
ReCode Therapeutics, Inc.
 ReCode Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ReCode Therapeutics, Inc. operates as a biopharmaceutical company. It develops precision medicines for pulmonary diseases. The company is headquartered in Irvin, TX. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Founder Private Equity Investor | |
| Harvard T.H. Chan School of Public Health | College/University | Graduate Degree Graduate Degree | |
Cell Cure Neurosciences Ltd.
 Cell Cure Neurosciences Ltd. BiotechnologyHealth Technology Cell Cure Neurosciences Ltd. develops cell therapies for neural degenerative diseases. Its therapeutic cells include retinal pigmented epithelial (RPE) cells and neural progenitor cells. The firm's cells are derived from human embryonic stem cells (hESCs), which are considered to be the gold standard source of cells for the development of stem cell therapies. The company was founded in 2005 and is headquartered in Jerusalem, Israel. | Biotechnology | Chairman Director/Board Member | |
Iterum Therapeutics US Holding Ltd.
 Iterum Therapeutics US Holding Ltd. Financial ConglomeratesFinance Iterum Therapeutics US Holding Ltd. operates as a clinical-stage pharmaceutical company. The company was founded in 2018 and is headquartered in Chicago, IL. | Financial Conglomerates | Director/Board Member Director/Board Member | |
Iterum Therapeutics International Ltd.
 Iterum Therapeutics International Ltd. Pharmaceuticals: MajorHealth Technology Iterum Therapeutics International Ltd. engages in the development of clinical-stage pharmaceutical products. The company was founded in 2015 and is headquartered in Dublin, Ireland. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Ortho-Clinical Diagnostics, Inc.
 Ortho-Clinical Diagnostics, Inc. Medical SpecialtiesHealth Technology Ortho-Clinical Diagnostics, Inc. engages in the manufacture and design of diagnostic, transfusion, clinical equipment, and systems. It provides solutions for screening, diagnosing, monitoring, and confirming diseases early before they put lives at risk. Its products include instrument systems and reagents that screen for AIDS and hepatitis C, as well as blood typing systems. The company was founded in 1939 and is headquartered in Raritan, NJ. | Medical Specialties | Corporate Officer/Principal | |
| NUVATION BIO INC. | Biotechnology | Corporate Officer/Principal |
Statistics
International
| United States | 45 |
| Ireland | 4 |
| Singapore | 2 |
| Hong Kong | 2 |
| Israel | 2 |
Sectoral
| Health Technology | 28 |
| Consumer Services | 15 |
| Finance | 6 |
| Commercial Services | 3 |
| Communications | 2 |
Operational
| Director/Board Member | 228 |
| Corporate Officer/Principal | 125 |
| Independent Dir/Board Member | 73 |
| Chief Executive Officer | 52 |
| Chairman | 48 |
Most connected contacts
| Insiders | |
|---|---|
| Luke Evnin | 42 |
| Alan Colowick | 30 |
| Ron Hunt | 29 |
| Mark Chin | 25 |
| Andy Arno | 25 |
| Jeffrey L. Cleland | 21 |
| Michael West | 21 |
| Patrick Baeuerle | 19 |
| Joanne Viney | 18 |
| Georgia Erbez | 18 |
| Scott Myers | 18 |
| Russell Skibsted | 17 |
| Pedro Lichtinger | 16 |
| Alfred Kingsley | 16 |
| Julia Eastland | 16 |
- Stock Market
- Insiders
- Frank Lanza
- Company connections
